Larimar Therapeutics Inc
NASDAQ:LRMR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
|
J
|
Jardine Cycle & Carriage Ltd
XMUN:CYC
|
SG |
|
H
|
HEICO Corp
F:HC1
|
US |
|
Just Eat Takeaway.com NV
LSE:JET
|
NL |
|
Magic Software Enterprises Ltd
NASDAQ:MGIC
|
IL |
|
S
|
Standard Chartered PLC
XMUN:STD
|
UK |
|
S
|
Soitec SA
LSE:0RMT
|
FR |
|
P
|
Pacific Biosciences of California Inc
F:P09
|
US |
|
P
|
Paradigm Biopharmaceuticals Ltd
OTC:PBIGF
|
AU |
|
Canfor Corp
TSX:CFP
|
CA |
|
Route Mobile Ltd
NSE:ROUTE
|
IN |
|
APG SGA SA
F:279
|
CH |
|
C
|
Canafarma Hemp Products Corp
CNSX:CNFA
|
CA |
Bankruptcy Probability
Larimar Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Larimar Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
384.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Larimar Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Larimar Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
